Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,203,753
  • Shares Outstanding, K 102,273
  • Annual Sales, $ 84,450 K
  • Annual Income, $ -68,330 K
  • 60-Month Beta 2.84
  • Price/Sales 14.17
  • Price/Cash Flow N/A
  • Price/Book 3.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.27
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.37
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -17.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.76 +36.99%
on 03/25/19
13.91 -13.73%
on 04/02/19
+3.11 (+34.98%)
since 03/22/19
3-Month
6.26 +91.69%
on 02/07/19
13.91 -13.73%
on 04/02/19
+0.94 (+8.50%)
since 01/23/19
52-Week
6.26 +91.69%
on 02/07/19
19.25 -37.66%
on 09/04/18
-6.15 (-33.88%)
since 04/23/18

Most Recent Stories

More News
Sangamo Therapeutics Announces Presentations At 2019 Annual Meeting Of The American Society Of Gene & Cell Therapy

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced that Sangamo scientists and collaborators will present data from the Company's clinical and preclinical pipeline at...

SGMO : 12.00 (+1.95%)
18.4% Return Seen to Date on SmarTrend Sangamo Therapeu Call (SGMO)

SmarTrend identified an Uptrend for Sangamo Therapeu (NASDAQ:SGMO) on March 4th, 2019 at $10.20. In approximately 1 month, Sangamo Therapeu has returned 18.43% as of today's recent price of $12.08.

SGMO : 12.00 (+1.95%)
Potential Blockbuster Gene Therapy Programs to Watch in 2019

Several revolutionary gene therapies appear to be on the verge of delivering remarkable remedies for diseases that have previously been viewed as untreatable.

SGMO : 12.00 (+1.95%)
QURE : 55.06 (+4.36%)
BLUE : 139.09 (+2.63%)
LPTX : 1.72 (+1.78%)
GNPX : 1.79 (+4.75%)
Sangamo Therapeu Set to Possibly Pullback After Yesterday's Rally of 1.11%

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $12.55 to a high of $12.75. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high...

SGMO : 12.00 (+1.95%)
Biotech Brief: U.S. Medical Device Market Reaches $156 Billion Mark

Medical technology is an area where the U.S. companies are at the forefront. In fact, according to recent industry publication the: "U.S. remains the largest medical device market in the world, with a...

SGMO : 12.00 (+1.95%)
MLNT : 4.59 (+7.24%)
TTOO : 2.64 (+2.33%)
PFE : 39.42 (+1.13%)
SOLY : 13.72 (+11.64%)
Sangamo Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the completion of its previously announced underwritten public offering of 12,650,000 shares of its common stock at a price to the public of $11.50...

SGMO : 12.00 (+1.95%)
Uptrend Call Working As Sangamo Therapeu Stock Rises 17.1% (SGMO)

SmarTrend identified an Uptrend for Sangamo Therapeu (NASDAQ:SGMO) on March 4th, 2019 at $10.20. In approximately 1 month, Sangamo Therapeu has returned 17.06% as of today's recent price of $11.94.

SGMO : 12.00 (+1.95%)
Sangamo Therapeutics Announces Pricing of Public Offering of Common Stock

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a price to the public of $11.50 per share. All of the...

SGMO : 12.00 (+1.95%)
Sangamo Therapeu has the Best Relative Performance in the Biotechnology Industry (SGMO , CHRS , STML , SPPI , ARWR)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

SGMO : 12.00 (+1.95%)
ARWR : 19.07 (+2.91%)
STML : 14.01 (+5.26%)
CHRS : 14.18 (-2.54%)
Sangamo Therapeutics Announces Proposed Public Offering of Common Stock

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares are being offered by Sangamo. In addition,...

SGMO : 12.00 (+1.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade SGMO with:

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

2nd Resistance Point 12.43
1st Resistance Point 12.21
Last Price 12.00
1st Support Level 11.66
2nd Support Level 11.33

See More

52-Week High 19.25
Fibonacci 61.8% 14.29
Fibonacci 50% 12.76
Last Price 12.00
Fibonacci 38.2% 11.22
52-Week Low 6.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar